The primary catalyst is the VYD2311 data readout expected within weeks. Traders should monitor for the DECLARATION and LIBERTY results, which will determine the BLA filing path and the stock's near-term direction. The CEO change is a neutral administrative event.
Price Chart
Executive Summary
Invivyd appointed Chairman Marc Elia as CEO, replacing the CFO who had been serving as principal executive officer. The filing also announced top-line data from the VYD2311 Phase 3 DECLARATION and LIBERTY studies is expected around the end of Q3 2026, with the company planning to submit a BLA for either traditional or accelerated approval. This is a routine CEO appointment combined with a near-term binary catalyst from pivotal clinical readouts.
Key Facts
- Marc Elia appointed CEO effective August 30, 2026; he retains Chairman title.
- Elia receives $750,000 base salary, 70% target bonus, $500,000 sign-on bonus, and an option for 10,700,000 shares.
- Top-line data from VYD2311 DECLARATION and LIBERTY studies expected around end of Q3 2026.
- Company plans to submit a BLA for VYD2311 for either traditional or accelerated approval after data readout.
- Ian Sheffield appointed to the Board as an independent director; Ajay Royan appointed Lead Independent Director.
Financial Impact
CEO compensation package includes $750K salary, $500K sign-on bonus, and 10.7M share option grant. VYD2311 BLA submission is a binary catalyst with no disclosed financial terms.
Risk Factors
- VYD2311 clinical data may fail to meet statistical endpoints, delaying or preventing BLA submission.
- Potential dilution from the 10.7M share option grant to the new CEO.
- The company has a history of poor stock performance following prior reports, with an 11% win rate at T+20.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-377493 |
| Document: ivvd-20260830.htm | 0001193125-26-377493 |
| Document: ivvd-ex99_1.htm | 0001193125-26-377493 |
| Document: 0001193125-26-377493-index-headers.html | 0001193125-26-377493 |
| Document: 0001193125-26-377493-index.html | 0001193125-26-377493 |
| Document: 0001193125-26-377493.txt | 0001193125-26-377493 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $0.8800 $0.8441 | ▼ −4.08% | ▼ −5.26% | $0.8221 (−6.58%) |
Aug 17, 2026 6w ago | 144 | $0.8680 $0.8198 | ▼ −5.55% | ▼ −4.56% | $0.8221 (−5.29%) |
Jul 6, 2026 12w ago | 8-K | $0.8340 $0.5350 | ▲ +35.85% | ▲ +35.29% | $0.8221 (+1.43%) |
Jun 16, 2026 15w ago | Press Release | $0.8918 $0.8008 | ▼ −10.20% | ▼ −10.40% | $0.8221 (−7.82%) |
Jun 11, 2026 16w ago | Institutional Cluster | $0.8125 $0.8037 | ▼ −1.08% | ▼ −2.97% | $0.8221 (+1.18%) |
Jun 9, 2026 16w ago | Press Release | $0.9900 $0.9418 | ▼ −4.87% | ▼ −6.32% | $0.8221 (−16.96%) |
Jun 1, 2026 17w ago | Press Release | $1.22 $0.8724 | ▼ −28.49% | ▼ −27.19% | $0.8221 (−32.61%) |
May 14, 2026 20w ago | 8-K | $1.16 $0.7700 | ▼ −33.62% | ▼ −32.76% | $0.8221 (−29.13%) |
May 14, 2026 20w ago | Press Release | $1.16 $0.7700 | ▼ −33.62% | ▼ −32.76% | $0.8221 (−29.13%) |
Apr 9, 2026 25w ago | 8-K | $1.78 $1.46 | ▼ −17.98% | ▼ −25.55% | $0.8221 (−53.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access